Consensus XP Inc. Buenos Aires S.E.

Stocks

XP

ARBCOM4603Z1

Investment Banking & Brokerage Services

End-of-day quote Buenos Aires S.E. 2026-10-15			5-day change	1st Jan Change
12,110.00 ^ARS	-1.30%		-0.41%	+91.61%

Sep. 18	XP Insider Sold Shares Worth $2,413,865, According to a Recent SEC Filing	MT
Sep. 14	Brazil derivatives exchange A5X raises $70 million in new funding round	RE

306ac3f5eefdcb4529151360cf54.e5Ql543o3mvBEdLFEqMoslWnEQfmCwudzuzzkH5TuSM.Ee5qrb--6lLyfoGaSNp-3STkeUXUW032l7q89UkhwGA4_0-uv8WaBIR6kw~036b275c249f146743a031088d3a5100

Analysts' recommendations: XP Inc.

Oct. 08	UBS Adjusts Price Target on XP to $37 From $25, Keeps Buy Rating	MT
Oct. 06	XP Shares Rise After Itau BBA Upgrade	MT
Oct. 06	Itau BBA Upgrades XP to Outperform From Market Perform, Adjusts Price Target to $27 From $19	MT
Aug. 31	Itau BBA Upgrades XP to Outperform From Market Perform, Adjusts PT to $22 From $19	MT
Apr. 02	UBS Adjusts Price Target on XP to $28 From $25, Maintains Buy Rating	MT
Jan. 20	Jefferies Initiates XP at Buy With $22 Price Target	MT
Dec. 16	UBS Adjusts XP Price Target to $25 From $23, Maintains Buy Rating	MT
25-10-16	UBS Adjusts Price Target on XP to $23 From $24, Maintains Buy Rating	MT
25-06-23	XP Shares Drop After Downgrade From Itau BBA	MT
25-06-23	Itau BBA Downgrades XP to Market Perform From Outperform, Adjusts Price Target to $21 From $20	MT
25-06-10	UBS Adjusts XP Price Target to $24 From $17, Maintains Buy Rating	MT
25-06-04	Goldman Sachs Upgrades XP to Buy From Neutral, $23 Price Target	MT
25-05-13	XP Shares Rise After Morgan Stanley Upgrades to Overweight From Equalweight	MT
25-05-13	Morgan Stanley Upgrades XP to Overweight From Equalweight, Adjusts Price Target to $24 From $18	MT
25-04-07	UBS Adjusts Price Target on XP to $17 From $16, Keeps Buy Rating	MT
25-03-18	Itau BBA Initiates XP at Outperform With $20 Price Target	MT
25-01-24	XP Shares Rise After Upgrade From UBS	MT
25-01-24	UBS Upgrades XP to Buy From Neutral, Cuts Price Target to $16 From $19	MT
24-12-10	BofA Securities Downgrades XP to Neutral From Buy, Price Target is $16	MT
24-11-25	UBS Cuts Price Target on XP to $19 From $21, Maintains Neutral Rating	MT
24-07-11	UBS Downgrades XP to Neutral From Buy, Cuts Price Target to $21 From $30	MT
24-07-05	Bradesco BBI Downgrades XP to Neutral From Outperform, Cuts Price Target to $19 From $31	MT
24-06-05	Citigroup Adjusts Price Target on XP to $27 From $29, Maintains Buy Rating	MT
24-04-30	XP Shares Decline After Goldman Sachs Downgrade	MT
24-04-30	Goldman Sachs Downgrades XP to Neutral From Buy, Cuts Price Target to $23 From $30	MT

More recommendations

Brokerage Services

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	MORGAN STANLEY					+17.74%
	THE GOLDMAN SACHS GROUP, INC.					+16.37%
	CITIGROUP INC.					+22.32%
	CHARLES SCHWAB					+28.36%
	BANCO BTG PACTUAL S.A.					-8.25%
	CITIC SECURITIES COMPANY LIMITED					+44.88%
	EAST MONEY INFORMATION CO.,LTD.					+44.02%
	GUOTAI HAITONG SECURITIES CO., LTD.					+46.52%
	INTERACTIVE BROKERS GROUP, INC.					+21.66%
	Average					+25.96%
	Weighted average by Cap.					+21.52%